Spleen cells from 2-to 3-month-old normal mice of some strains having a low incidence of spontaneous leukemia were found to lyse cells of the spontaneous AKR
and in mice immunized against viral and chemical induced syngeneic leukemias (3) (4) (5) . Although antibodies to structural proteins of the vertically transmitted leukemia viruses (6) (7) (8) and to antigens associated with leukemia cells (9) (10) (11) occur naturally in normal mice of strains of both high and low leukemia incidence, it is not clear whether a cell-mediated immune response against antigens associated with spontaneous leukemias also is elicited naturally in normal mice. Our study was undertaken to determine if lymphocytes of normal mice of strains differing in incidence of spontaneous leukemia were cytotoxic for AKR Leukemia AKR K36 originated as a spontaneous AKR thymoma and has been maintained by transplantation in ascites form. Leukemia EL4 was induced in a C57BL mouse with 9,10-dimethyl-1,2-benzanthracene (12) and has been maintained by transplantation in ascites form. Leukemia ERLD was a radiation-induced thymoma of C57BL/6 mice that had been maintained by transplantation of spleen cells. Leukemia NTD was from a thymoma induced in a W/Fu rat by neonatal inoculation of'thymus cells from C58 mice, and this murine leukemia virus (MuLV)-induced rat leukemia was maintained by transplantation of ascites cells in weanling W/Fu rats.
The AKR K36, EL4, and NTD cells were adapted to growth in vitro in RPMI-1640 (Grand Island Biological Co., New York) medium supplemented with penicillin (200 units/ml), streptomycin (200 Ag/ml), and 10% heat-inactivated fetal calf serum. R1, a tissue culture line from a spontaneous thymoma of C58 origin, was obtained from the Salk Institute and also was maintained in RPMI-1640. All leukemia cell lines were shown to be free of mycoplasma.
Immunizations. C57BL/6 mice were inoculated intraperitoneally (i.p.') with 2 X 107 AKR K36 cells. BALB/C mice were inoculated i.p. with 1.5 X 107 spleen cells from a W/Fu rat.
Detection of Cytotoxic Spleen Cells by the 51Cr Release Assay. Cell-mediated lysis was measured by the in vitro 51Cr release assay (13) . Leukemia AKR K36 was chosen as a standard target cell since it was derived from a spontaneous leukemia that has been characterized with respect to the expression of viral associated antigens (14) , AKR K36 cells could be maintained in culture, and these cells were sensitive to lysis by allogeneic immune spleen cells in the 51Cr-release assay.
( (Fig. 2) did not inhibit spleen cells from BALB/C mice immunized with rat spleen cells from lysing rat NTD leukemia cells (Fig. 3) was established with the demonstration that EL4 cells did not inhibit cell-mediated 51Cr release in an antigenically unrelated system. Furthermore, the addition of nonlabeled AKR thymus cells did not cause a greater reduction in C57BL/6 spleen cell-mediated 51Cr release from AKR K36 cells than did the addition of C57BL/6 thymus cells. The slight reduction in 51Cr release detected in the presence of high numbers of thymocytes was probably due to the protective effect of mouse thymocytes on the spontaneous release of 51Cr, since normal mouse thymocytes (but not leukemia cells or rat thymocytes) were found to protect labeled AKR K36 cells from releasing 5lCr spontaneously in the absence of effector cells. Thus, it was concluded that the antigen(s) of AKR K36 cells that was recognized by normal C57BL/6 mice was present on several different leukemia cells, but was not detected on normal mouse or rat thymus cells. It is possible that the antigen detected on the cells of several leukemias is a gene product of the vertically transmitted leukemia viruses (which are present in all mouse cells) that is expressed after transformation of the lymphocytes to malignancy. These genes also would be expressed in rat thymocytes after transformation by murine leukemia virus. Alternatively, the common antigen(s) detected in this assay may be an embryonic antigen(s) which is re-expressed after leukemia transformation of cells (11) or it may be a common cell surface antigen, unrelated to viral structural proteins or fetal antigens, that is expressed after malignant transformation of thymocytes. Along this line, it should be noted that we have not determined whether this antigen is restricted exclusively to leukemia cells; it may have a tissue distribution wider than that determined in this study.
In summary, results reported here demonstrate that spleen cells from normal mice of some strains that have a low incidence of spontaneous leukemia are cytotoxic for AKR leukemia cells in vttro. It is of interest to note that mice of two of these strains (RF and C57BL/6) develop a high incidence of leukemia after exposure to irradiation. In this case, radiation results in bone marrow injury, immunosuppression, and release of endogenous leukemia virus (for review, see ref. 18 ). Possibly even without overt exposure to radiation or chemical carcinogens, lymphocytes in mice of low leukemic strains undergo transformation periodically. Such cells would then express antigens against which an effective cell-mediated immune response could be elicited. Our demonstration that lymphocytes obtained from normal mice of these strains are cytotoxic for leukemia cells supports this hypothesis. Although antibodies to endogenous leukemia viruses (6) (7) (8) and antibodies cytotoxic for leukemia cells have been found in mice of several high and low leukemia strains of mice (Nowinski, in preparation), it may be of significance that anti-leukemic "killer" cells were detected only in mice of low leukemic strains.
During the preparation of this manuscript we became aware that Dr. R. Kiessling and his colleagues (19, 20) have found that spleen cells of young normal mice of some genotypes lyse Moloney leukemia cells (YAC) in vitro. Similar to results reported here, they have found that spleen cells from C57BL/6 and C57L mice killed YAC cells, and that removal of macrophages from normal spleen cell suspensions did not decrease the cytotoxic activity. It remains to be determined whether the antigens expressed on AKR spontaneous leukemias and Moloney virus-induced leukemias against which normal spleen cells are directed are the same.
